First-in-Human trial launches for promising new cancer fighter
NCT ID NCT07193511
Summary
This is the first-ever study in people for a new experimental drug called AVZO-103. It aims to find a safe and effective dose for adults with advanced cancers that have spread, including bladder cancer. The study will test the drug alone and in combination with other therapies to see if it can shrink tumors.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC SOLID TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Avenzo Therapeutics Recruiting Site
RECRUITINGOrlando, Florida, 32827, United States
-
Avenzo Therapeutics Recruiting Site
RECRUITINGBoston, Massachusetts, 02114, United States
-
Avenzo Therapeutics Recruiting Site
RECRUITINGMyrtle Beach, South Carolina, 29572, United States
-
Avenzo Therapeutics Recruiting Site
RECRUITINGNashville, Tennessee, 37203, United States
-
Avenzo Therapeutics Recruiting Site
RECRUITINGAustin, Texas, 78758, United States
-
Avenzo Therapeutics Recruiting Site
RECRUITINGIrving, Texas, 75039, United States
Conditions
Explore the condition pages connected to this study.